Revitalist Enters Joint-Venture Partnership with GCM Partners, LLC, Expanding Access to an Additional 50,000 Patients


Share Post:

VANCOUVER, BC, April 11, 2023 — REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4D0O) announces an exciting joint-venture partnership where Revitalist will gain access to five new locations in Chicago, IL (2), Orlando, FL
(2), and Miami, FL. These centrally located offices will now be able to serve patients with the Revitalist Ketamine protocols, providing them access to this much needed therapy.

Revitalist has entered a joint-venture agreement with GCM Partners, LLC, expanding the capability of Revitalist and Wake Network to offer contractual agreements for licensing and managed services across the United States for medical clinics, behavioral clinics, and hospital facilities. License offerings include all necessary service structures to providers and business operators supporting ketamine therapy services.

The joint-venture agreement expands Revitalist’s virtual telemedicine services and supports offerings to patients to manage mental health and pain conditions utilizing ketamine therapies, medical-grade CBD offerings, and functional mushrooms. Service offerings will also include
weaning protocols for patients wishing to discontinue their antidepressants, benzodiazepines, and/or narcotic medications.

Revitalist brick-and-mortar services are imminently available in the following locations:
Miami, FL; Orlando, FL (2); Tampa, FL; Chicago, IL (2); Johnson City, TN; Knoxville, TN, as well as a managed service agreement with Monarch Athletic Club in Los Angeles, CA.

Virtual service offerings are available in the following 33 states increasing access to more than 200 million Americans: Arizona, California, Colorado, Florida, Georgia, Illinois, lowa, Kentucky, Maine, Maryland, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, New
Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. “Given the termination of the COVID-19 emergency order on April 10, 2023 [H.J.Res.7], any operator in
this space must have as part of its strategy telemedicine and brick-and-mortar capabilities,” says Dr. George Gavrilos, Pharm.D., M.A., BCCCP, CEO of GCM Partners, LLC.


Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is one of the largest publicly listed, ketamine focused clinic operations operating in the United States. Each clinic enables access to psychedelic medicine, vitamin infusions and other lifestyle optimization
services provided by medical and behavioral professionals. Since opening their first clinic in 2018, Revitalist has provided thousands of ketamine infusions through its network serving clinic operations as well as virtual telemedicine across 33 states. Its founder and CEO, Kathryn
Walker, works as a lead provider and thought leader in the psychedelic space. For additional information and to be added to the Company’s mailing list, please click here.


Since 2017, GCM Partners, LLC, in conjunction with the medical practice it supports, Green Care Professional Services, P.C., has serviced more than 50,000 patients in the areas of metabolic disorders, men’s and women’s health, weight loss, pain management, mental health (including
anxiety, depression, and PTSD), and sleep disorders. The GCPS/GCM team has operated several brands in the alternative-health spaces, including Green Care Medical, US Med Card, Ketavera, TripSitter, NUFIX, and Leafwell, across more than 30 states, pioneering medical-cannabis and
ketamine treatment in the U.S. GCM is led by CEO Dr. George S. Gavrilos, Pharm.D., M.A, BCCCP, and GCPS is led by CEQ Dr. Steven L. Salzman, D.O.


Wake Network, Inc. is a vertically integrated, naturally derived psilocybin bioscience company focused on advancing the field of psychedelic and fungi-based therapeutics to address the growing need for mental health support in medicine and society at large. Wake is currently pro-
ducing standardization of dosing for fungus-derived psilocybin and medicinal mushrooms while simultaneously establishing proprietary remote monitoring wellness platforms with a goal to maximize safety. Wake is honored to have worked with ESPN E:60 for the release of their upcoming psychedelic documentary, “Peace of Mind”, being released on April 23, 2023.

Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd.
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd

On Behalf of the Board
Kathryn Walker
Chief ExecuRve Officer

Stay Connected

More Press Releases

Psychedelic Community Reacts To FDA Committee’s Critique Of Lykos’ MDMA Studies Guest Column | June 14, 2024 As told to Abby Proch, executive editor of